Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Ticker SYIN · OTC · FL
Synbio International, Inc. is a U.S. business entity operating within the Computer Processing & Data Preparation sector (SIC 7374). Publicly traded on the OTC under the ticker symbol SYIN, the company is incorporated in Florida. Our proprietary Semantic Risk Score of 34 indicates moderate transparency based on filing patterns, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 7374 classification, Synbio International, Inc. serves as a key benchmark for investors and analysts monitoring Florida corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Federal Contracts
DARPA CONTRACT AWARD (BASE) "SUPERB: SYNBIO + UNIVERSAL PURIFICATION OF EXTRACT-DERIVED, RIGHT-ON-TIME BIOLOGICS"
TUBERCULIN, PPD BOVIS INTRADERMIC 10 ML VIALS
PURCHASE OF 7692 BOTTLES OF TUBERCULIN AT $26.00 PER BOTTLE
MYCOBACTERIUM BOVIS PPD FOR USE IN US TB ERADICATION PROGRAM.
TUBERCULIN, PPD, 10ML VIALS.
CONTRACT NUMBER: AG-6395-C-08-0080 OPTION QUANTITY UNDER BASE LINE CONTRACT ITEM FOR FY2008.PURCHASE OPTION QUANTITY 1 FOR 10,000 VIALS OF BOVINE TUBERCULIN AT A COST OF $275,000.00
SYNBIO TECHNOLOGIES (AMBIS #1981626)
SYNBIOBETA SPONSORSHIP
BRONZE SPONSORSHIP FOR SYNBIOBETA CONFERENCE HELD OCTOBER 1-3, 2019 IN SAN FRANCISCO, CALIFORNIA
IGF::OT::IGF BRONZE SPONSORSHIP AT THE SYNBIOBETA CONFERENCE THAT WILL BE HELD OCTOBER 3-5, 2017
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →